This company has been marked as potentially delisted and may not be actively trading. Can B (CANB) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesTrendsBuy This Stock CANB vs. MEDS, BIMI, MCK, COR, CAH, HLF, NUS, COSM, HWH, and PSTVShould you be buying Can B stock or one of its competitors? The main competitors of Can B include TRxADE HEALTH (MEDS), BIMI (BIMI), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), HWH International (HWH), and Plus Therapeutics (PSTV). Can B vs. Its Competitors TRxADE HEALTH BIMI McKesson Cencora Cardinal Health Herbalife Nu Skin Enterprises Cosmos Health HWH International Plus Therapeutics TRxADE HEALTH (NASDAQ:MEDS) and Can B (NASDAQ:CANB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, community ranking, risk and institutional ownership. Which has more volatility and risk, MEDS or CANB? TRxADE HEALTH has a beta of 2.32, indicating that its share price is 132% more volatile than the S&P 500. Comparatively, Can B has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Which has higher earnings & valuation, MEDS or CANB? Can B has lower revenue, but higher earnings than TRxADE HEALTH. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTRxADE HEALTH$7.45M0.21-$17.84MN/AN/ACan B$2.16M0.76-$9.74MN/AN/A Do insiders & institutionals have more ownership in MEDS or CANB? 5.7% of TRxADE HEALTH shares are held by institutional investors. Comparatively, 6.1% of Can B shares are held by institutional investors. 48.4% of TRxADE HEALTH shares are held by insiders. Comparatively, 11.4% of Can B shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media prefer MEDS or CANB? In the previous week, TRxADE HEALTH's average media sentiment score of 0.00 beat Can B's score of -0.14 indicating that TRxADE HEALTH is being referred to more favorably in the media. Company Overall Sentiment TRxADE HEALTH Neutral Can B Neutral Does the MarketBeat Community prefer MEDS or CANB? TRxADE HEALTH received 4 more outperform votes than Can B when rated by MarketBeat users. However, 58.62% of users gave Can B an outperform vote while only 52.50% of users gave TRxADE HEALTH an outperform vote. CompanyUnderperformOutperformTRxADE HEALTHOutperform Votes2152.50% Underperform Votes1947.50% Can BOutperform Votes1758.62% Underperform Votes1241.38% Is MEDS or CANB more profitable? TRxADE HEALTH has a net margin of -149.81% compared to Can B's net margin of -1,238.33%. Can B's return on equity of 0.00% beat TRxADE HEALTH's return on equity.Company Net Margins Return on Equity Return on Assets TRxADE HEALTH-149.81% -196.79% -112.21% Can B -1,238.33%N/A -218.65% SummaryTRxADE HEALTH beats Can B on 7 of the 12 factors compared between the two stocks. Get Can B News Delivered to You Automatically Sign up to receive the latest news and ratings for CANB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CANB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CANB vs. The Competition Export to ExcelMetricCan BDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.63M$22.76B$5.56B$8.50BDividend YieldN/A1.30%5.28%4.16%P/E RatioN/A11.8526.6419.64Price / Sales0.769.91407.99152.17Price / CashN/A12.9538.2534.64Price / Book-0.0733.586.964.60Net Income-$9.74M$785.39M$3.23B$248.06M Can B Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CANBCan BN/A$0.02+8.3%N/A+4.7%$1.63M$2.16M0.0016MEDSTRxADE HEALTHN/A$1.10+3.8%N/A-82.4%$1.55M$7.45M0.0050Gap DownBIMIBIMIN/A$0.00flatN/A-100.0%$3K$12.63M0.00520Positive NewsMCKMcKesson4.3698 of 5 stars$705.18-0.4%$692.46-1.8%+23.0%$88.23B$359.05B32.2975,000Trending NewsAnalyst ForecastCORCencora4.4951 of 5 stars$284.32+0.1%$306.91+7.9%+27.1%$55.11B$638.56M40.4442,000Positive NewsCAHCardinal Health4.4226 of 5 stars$153.07-0.4%$150.57-1.6%+60.3%$36.54B$222.29B28.5646,500Trending NewsAnalyst ForecastHLFHerbalife4.4749 of 5 stars$8.29+4.5%$11.50+38.8%-30.3%$843.90M$4.95B3.3310,100Positive NewsNUSNu Skin Enterprises3.2455 of 5 stars$8.39+4.3%$6.88-18.0%-41.4%$414.33M$1.68B-2.8413,400Positive NewsCOSMCosmos Health2.5479 of 5 stars$0.49+1.9%N/A-33.2%$14.06M$53.55M-0.20100Positive NewsShort Interest ↓Gap DownHWHHWH InternationalN/A$1.29-3.0%N/A-71.0%$8.35M$1.26M0.00N/AShort Interest ↓PSTVPlus Therapeutics2.2962 of 5 stars$0.35+0.5%$11.67+3,234.3%-85.3%$5.95M$4.91M-0.1420Short Interest ↓Gap Up Related Companies and Tools Related Companies MEDS Competitors BIMI Competitors MCK Competitors COR Competitors CAH Competitors HLF Competitors NUS Competitors COSM Competitors HWH Competitors PSTV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CANB) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can B Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can B With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CANB Stock Free CANB Stock Alerts